Koyfin Home > Directory > Health Care > Amedisys Inc > Cost of Goods Sold

Amedisys Inc Cost of Goods Sold Chart (AMED)

Amedisys Inc annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Amedisys Inc Cost of Goods Sold for the quarter ending September 09, 2020 was $294m a -0.60% decrease of -2m year over year
  • Amedisys Inc Cost of Goods Sold for the last 12 months ending September 09, 2020 was $1,143m a -0.61% decrease of -7m year over year
  • Amedisys Inc Annual Cost of Goods Sold for 2019 was $1,150m a 13.69% increase of 157m from 2018
  • Amedisys Inc Annual Cost of Goods Sold for 2018 was $993m a 9.01% increase of 89m from 2017
  • Amedisys Inc Annual Cost of Goods Sold for 2017 was $903m a 7.64% increase of 69m from 2016
Other Income Statement Metrics:
  • Amedisys Inc EBITDA for the quarter ending December 12, 2018 was $40m a 0.52% increase of 0m year over year
  • Amedisys Inc Net Income for the quarter ending December 12, 2018 was $27m a 1.10% increase of 0m year over year
  • Amedisys Inc Total Revenue for the quarter ending December 12, 2018 was $434m a 8.08% increase of 35m year over year
View Chart On Koyfin

Quarterly AMED Cost of Goods Sold Data

09/2020$294m
06/2020$270m
03/2020$285m
12/2019$296m
09/2019$289m
06/2019$291m
03/2019$275m
12/2018$262m
09/2018$250m
06/2018$243m

Annual AMED Cost of Goods Sold Data

2019$1,150m
2018$993m
2017$903m
2016$834m
2015$726m
2014$690m
2013$718m
2012$811m
2011$750m
2010$794m